REV1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of REV1 monoclonal antibodies for research focused on understanding REV1's role in DNA repair and translesion synthesis. REV1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). REV1 plays a crucial role in the DNA damage response by facilitating the bypass of DNA lesions during replication. The function of REV1 is essential for maintaining genomic stability and preventing mutations that can lead to cancer. Research into REV1 mechanisms continues to reveal new insights about DNA repair pathways and their regulation. Understanding REV1's cellular functions helps identify potential therapeutic targets for diseases linked to DNA repair deficiencies. Investigating REV1's interactions with other DNA repair proteins provides valuable information about genome maintenance systems. Ongoing studies of REV1 contribute to developing new treatment strategies for cancer and other diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DNA repair mechanisms and their impact on human health.